Literature DB >> 28003596

A Case Study of Rat Bite Fever Caused by Streptobacillus moniliformis.

Yasue Hayakawa1, Jun Suzuki2, Masahiro Suzuki3, Wataru Sugiura4, Kiyofumi Ohkusu5.   

Abstract

We report a case of rat bite fever, diagnosed based on positive cultures of Streptobacillus moniliformis from blood and synovial fluid. The patient was a 45-year-old man who presented with history of a rat bite and alcoholic liver cirrhosis. He had been bitten on his third finger by a rat, which was caught in a mousetrap installed in his house. Over the course of approximately 2 weeks after the bite, the patient developed fever, rash, and arthralgia. The patient was admitted to our hospital and treated with a combination of ampicillin-sulbactam, vancomycin (VAN), and minocycline (MIN) antibiotics. Initial culture findings from the Anaerobic/F resin blood culture were positive for gram-negative bacillus after overnight incubation. Thus, S. moniliformis infection was suspected, and administration of VAN and MIN was ceased. On hospital day 8, the treatment was switched to oral amoxicillin-clavulanic acid, and the patient was discharged from the hospital. Subsequently, the pathogen was also detected in synovial fluid and identified as S. moniliformis using 16S rRNA sequencing analysis.

Entities:  

Keywords:  16S rRNA sequencing; Streptobacillus moniliformis; rat bite fever

Mesh:

Substances:

Year:  2016        PMID: 28003596     DOI: 10.7883/yoken.JJID.2016.270

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  2 in total

1.  Streptobacillus moniliformis mitral valve endocarditis and septic arthritis: the challenges of diagnosing rat-bite fever endocarditis.

Authors:  Daisy Torres-Miranda; Mahdi Moshgriz; Marc Siegel
Journal:  Infect Dis Rep       Date:  2018-09-24

Review 2.  Health Monitoring of Laboratory Rodent Colonies-Talking about (R)evolution.

Authors:  Stephanie Buchheister; André Bleich
Journal:  Animals (Basel)       Date:  2021-05-14       Impact factor: 2.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.